| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Human T-lymphotropic virus 1 | 41 | 2013 | 98 | 6.170 |
Why?
|
| Gene Products, tax | 35 | 2013 | 74 | 6.120 |
Why?
|
| Gene Expression Regulation, Viral | 15 | 2011 | 187 | 2.020 |
Why?
|
| DNA Repair | 14 | 2013 | 1872 | 1.100 |
Why?
|
| Terminal Repeat Sequences | 8 | 2011 | 27 | 1.060 |
Why?
|
| Cell Transformation, Viral | 6 | 2008 | 138 | 0.980 |
Why?
|
| DNA Damage | 7 | 2013 | 1954 | 0.910 |
Why?
|
| Transcriptional Activation | 13 | 2008 | 1070 | 0.880 |
Why?
|
| Transcription, Genetic | 15 | 2011 | 3154 | 0.860 |
Why?
|
| Proliferating Cell Nuclear Antigen | 6 | 2008 | 195 | 0.770 |
Why?
|
| DNA, Viral | 10 | 2011 | 694 | 0.700 |
Why?
|
| G1 Phase | 3 | 2013 | 285 | 0.660 |
Why?
|
| Oncogenic Viruses | 2 | 2008 | 18 | 0.590 |
Why?
|
| Promoter Regions, Genetic | 11 | 2011 | 3101 | 0.530 |
Why?
|
| S Phase | 3 | 2013 | 281 | 0.520 |
Why?
|
| Cell Nucleus | 4 | 2011 | 1620 | 0.520 |
Why?
|
| HTLV-I Infections | 3 | 2007 | 16 | 0.510 |
Why?
|
| Deltaretrovirus | 2 | 2011 | 7 | 0.500 |
Why?
|
| Deltaretrovirus Infections | 3 | 2011 | 7 | 0.480 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2011 | 57 | 0.470 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 5 | 1997 | 362 | 0.470 |
Why?
|
| Cell Line | 17 | 2011 | 5114 | 0.450 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2007 | 2359 | 0.440 |
Why?
|
| Mutagens | 2 | 2006 | 187 | 0.430 |
Why?
|
| Human T-lymphotropic virus 3 | 1 | 2011 | 1 | 0.420 |
Why?
|
| RNA, Antisense | 1 | 2011 | 69 | 0.410 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 214 | 0.400 |
Why?
|
| Antigens, Nuclear | 1 | 2011 | 119 | 0.380 |
Why?
|
| Cell Polarity | 1 | 2011 | 208 | 0.370 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 216 | 0.360 |
Why?
|
| Serum Response Factor | 2 | 2007 | 51 | 0.360 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2007 | 323 | 0.360 |
Why?
|
| DNA-Binding Proteins | 8 | 2011 | 4821 | 0.350 |
Why?
|
| Virology | 1 | 2009 | 32 | 0.350 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2005 | 194 | 0.340 |
Why?
|
| RNA, Viral | 2 | 2011 | 671 | 0.330 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2007 | 19 | 0.310 |
Why?
|
| Peptide Fragments | 1 | 2013 | 1271 | 0.290 |
Why?
|
| Oncogene Proteins | 2 | 2008 | 354 | 0.290 |
Why?
|
| Trans-Activators | 5 | 2008 | 1555 | 0.280 |
Why?
|
| Karyopherins | 1 | 2006 | 136 | 0.260 |
Why?
|
| Serum Response Element | 1 | 2004 | 1 | 0.250 |
Why?
|
| Ultraviolet Rays | 5 | 2013 | 575 | 0.250 |
Why?
|
| Epithelial Cells | 1 | 2011 | 1818 | 0.240 |
Why?
|
| Cell Cycle Proteins | 3 | 2008 | 2045 | 0.240 |
Why?
|
| Binding Sites | 8 | 2007 | 2171 | 0.240 |
Why?
|
| Dinoprostone | 2 | 2004 | 208 | 0.230 |
Why?
|
| T-Lymphocytes | 3 | 2011 | 3869 | 0.230 |
Why?
|
| Genes, pX | 2 | 2001 | 4 | 0.220 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2008 | 3552 | 0.220 |
Why?
|
| Polyomavirus | 3 | 1987 | 30 | 0.220 |
Why?
|
| Virus Activation | 2 | 2004 | 228 | 0.220 |
Why?
|
| CD28 Antigens | 1 | 2003 | 202 | 0.220 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2008 | 1823 | 0.220 |
Why?
|
| Base Sequence | 11 | 2009 | 4917 | 0.220 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1997 | 445 | 0.210 |
Why?
|
| Genomic Instability | 1 | 2005 | 519 | 0.210 |
Why?
|
| Apoptosis | 4 | 2011 | 7591 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 591 | 0.210 |
Why?
|
| Jurkat Cells | 4 | 2011 | 311 | 0.200 |
Why?
|
| Rats | 6 | 2013 | 6086 | 0.200 |
Why?
|
| RNA, Messenger | 5 | 2013 | 6150 | 0.200 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2001 | 129 | 0.190 |
Why?
|
| Viral Proteins | 4 | 2009 | 435 | 0.190 |
Why?
|
| HeLa Cells | 8 | 2001 | 1643 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2013 | 1062 | 0.180 |
Why?
|
| Humans | 48 | 2013 | 261506 | 0.180 |
Why?
|
| Hepatitis B virus | 2 | 2005 | 217 | 0.180 |
Why?
|
| Cell Cycle | 4 | 2008 | 2084 | 0.180 |
Why?
|
| Molecular Sequence Data | 10 | 2009 | 6089 | 0.180 |
Why?
|
| DNA Replication | 3 | 2013 | 744 | 0.180 |
Why?
|
| HTLV-I Antibodies | 1 | 1998 | 4 | 0.170 |
Why?
|
| Poly A | 2 | 2011 | 87 | 0.170 |
Why?
|
| Cell Line, Transformed | 3 | 2011 | 394 | 0.170 |
Why?
|
| Chromosome Aberrations | 2 | 2005 | 1960 | 0.170 |
Why?
|
| Animals | 23 | 2013 | 59536 | 0.170 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2011 | 65 | 0.160 |
Why?
|
| Blotting, Western | 4 | 2013 | 3536 | 0.160 |
Why?
|
| Cells, Cultured | 5 | 2013 | 5637 | 0.160 |
Why?
|
| Leukemia, T-Cell | 3 | 2007 | 87 | 0.160 |
Why?
|
| Aneuploidy | 3 | 2005 | 369 | 0.160 |
Why?
|
| Protein Binding | 7 | 2007 | 3438 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2003 | 1146 | 0.150 |
Why?
|
| Plasmids | 3 | 2011 | 837 | 0.150 |
Why?
|
| Cytoplasm | 2 | 2011 | 652 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 3639 | 0.140 |
Why?
|
| Receptors, Virus | 2 | 1987 | 157 | 0.140 |
Why?
|
| Gene Expression | 4 | 2001 | 3570 | 0.140 |
Why?
|
| Virus Replication | 3 | 2008 | 709 | 0.140 |
Why?
|
| Response Elements | 2 | 2008 | 193 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1998 | 709 | 0.130 |
Why?
|
| Fibroblasts | 3 | 2013 | 1682 | 0.130 |
Why?
|
| Transcription Factors | 7 | 1997 | 5270 | 0.120 |
Why?
|
| Cell Survival | 3 | 2011 | 3045 | 0.110 |
Why?
|
| Pyrimidine Dimers | 1 | 2013 | 23 | 0.110 |
Why?
|
| Protein Phosphatase 2C | 1 | 2013 | 75 | 0.110 |
Why?
|
| Fungal Proteins | 1 | 1993 | 254 | 0.110 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1992 | 186 | 0.110 |
Why?
|
| Microtubule-Organizing Center | 1 | 2011 | 9 | 0.110 |
Why?
|
| Immunological Synapses | 1 | 2011 | 28 | 0.100 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1996 | 467 | 0.100 |
Why?
|
| Virus Latency | 2 | 2004 | 78 | 0.100 |
Why?
|
| Pheniramine | 1 | 2011 | 1 | 0.100 |
Why?
|
| Kidney | 3 | 2011 | 2146 | 0.100 |
Why?
|
| Neoplasms | 3 | 2008 | 15193 | 0.100 |
Why?
|
| Coordination Complexes | 1 | 2011 | 17 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 591 | 0.100 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 201 | 0.100 |
Why?
|
| Ku Autoantigen | 1 | 2011 | 79 | 0.100 |
Why?
|
| Palladium | 1 | 2011 | 56 | 0.100 |
Why?
|
| Microspheres | 1 | 2011 | 210 | 0.100 |
Why?
|
| COS Cells | 1 | 2011 | 377 | 0.100 |
Why?
|
| Flow Cytometry | 3 | 2013 | 3033 | 0.100 |
Why?
|
| Transfection | 5 | 2005 | 2944 | 0.100 |
Why?
|
| Gene Products, tat | 1 | 1989 | 54 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 741 | 0.090 |
Why?
|
| Proto-Oncogenes | 1 | 1989 | 202 | 0.090 |
Why?
|
| RNA Splicing | 1 | 2011 | 370 | 0.090 |
Why?
|
| NF-kappa B | 5 | 2005 | 1549 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1217 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2007 | 518 | 0.080 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 316 | 0.080 |
Why?
|
| Gene Expression Regulation | 4 | 2005 | 4053 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2003 | 8873 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 77 | 0.080 |
Why?
|
| Genome, Viral | 2 | 2009 | 155 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2013 | 4804 | 0.080 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1987 | 51 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 191 | 0.080 |
Why?
|
| fas Receptor | 1 | 2008 | 185 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2009 | 441 | 0.070 |
Why?
|
| Nuclear Proteins | 4 | 2008 | 3343 | 0.070 |
Why?
|
| Retroviridae | 1 | 2007 | 332 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 335 | 0.070 |
Why?
|
| Models, Biological | 3 | 2005 | 3254 | 0.070 |
Why?
|
| Mutation | 6 | 2008 | 15179 | 0.070 |
Why?
|
| Intranuclear Space | 1 | 2006 | 1 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 2216 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 574 | 0.070 |
Why?
|
| DNA, Antisense | 1 | 2006 | 42 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 1991 | 1688 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2007 | 11965 | 0.070 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2008 | 430 | 0.070 |
Why?
|
| Base Composition | 2 | 1997 | 92 | 0.070 |
Why?
|
| Histones | 1 | 2013 | 1466 | 0.070 |
Why?
|
| Capsid | 1 | 1985 | 103 | 0.070 |
Why?
|
| Gamma Rays | 1 | 2006 | 242 | 0.070 |
Why?
|
| Vanadates | 1 | 2004 | 21 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 52 | 0.060 |
Why?
|
| Ubiquitination | 1 | 2007 | 575 | 0.060 |
Why?
|
| Oncogenes | 1 | 2008 | 673 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2003 | 234 | 0.060 |
Why?
|
| Drug Interactions | 2 | 2000 | 553 | 0.060 |
Why?
|
| Genes, fos | 1 | 2004 | 53 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 834 | 0.060 |
Why?
|
| Genes, Reporter | 3 | 2005 | 798 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 182 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2003 | 13 | 0.060 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2003 | 28 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 1987 | 4367 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 803 | 0.060 |
Why?
|
| Leukocyte Common Antigens | 1 | 2003 | 188 | 0.060 |
Why?
|
| G2 Phase | 1 | 2003 | 206 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1996 | 220 | 0.060 |
Why?
|
| Alternative Splicing | 1 | 2006 | 584 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2008 | 671 | 0.050 |
Why?
|
| Mad2 Proteins | 1 | 2002 | 33 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2004 | 844 | 0.050 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2001 | 25 | 0.050 |
Why?
|
| Caspase Inhibitors | 1 | 2001 | 95 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2005 | 626 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2001 | 94 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1997 | 1555 | 0.050 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2001 | 35 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2001 | 196 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 1439 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2005 | 624 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2000 | 1258 | 0.050 |
Why?
|
| Point Mutation | 1 | 2004 | 769 | 0.050 |
Why?
|
| Cell Size | 1 | 2001 | 136 | 0.050 |
Why?
|
| Mitosis | 1 | 2003 | 615 | 0.050 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1991 | 118 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 1678 | 0.050 |
Why?
|
| Cell Division | 3 | 1998 | 2489 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 1033 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2008 | 1423 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2001 | 249 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 311 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 545 | 0.040 |
Why?
|
| Mice | 8 | 2011 | 34495 | 0.040 |
Why?
|
| HTLV-I Antigens | 1 | 1998 | 1 | 0.040 |
Why?
|
| Proviruses | 1 | 1998 | 21 | 0.040 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 1998 | 15 | 0.040 |
Why?
|
| Synovial Membrane | 1 | 1998 | 41 | 0.040 |
Why?
|
| Gene Products, gag | 1 | 1998 | 36 | 0.040 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1998 | 36 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2008 | 7226 | 0.040 |
Why?
|
| Cyclic AMP | 2 | 1996 | 358 | 0.040 |
Why?
|
| Interleukin-2 | 2 | 1992 | 842 | 0.040 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 1997 | 7 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2001 | 974 | 0.040 |
Why?
|
| Mutagenesis | 1 | 1999 | 483 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2007 | 886 | 0.040 |
Why?
|
| Rabbits | 1 | 1998 | 957 | 0.040 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1996 | 64 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 4233 | 0.040 |
Why?
|
| Transcription Factor AP-2 | 1 | 1996 | 79 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2002 | 1152 | 0.040 |
Why?
|
| Cricetinae | 1 | 1997 | 706 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1987 | 629 | 0.030 |
Why?
|
| Sp1 Transcription Factor | 1 | 1997 | 188 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1998 | 130 | 0.030 |
Why?
|
| Proteins | 1 | 2004 | 1963 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2000 | 1944 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 611 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2007 | 7222 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1493 | 0.030 |
Why?
|
| Virion | 2 | 2005 | 161 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2002 | 1664 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2000 | 1331 | 0.030 |
Why?
|
| Cisplatin | 1 | 2000 | 2432 | 0.030 |
Why?
|
| Chloroform | 1 | 1991 | 4 | 0.030 |
Why?
|
| United States | 1 | 2009 | 15433 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 1991 | 71 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 14551 | 0.030 |
Why?
|
| Zinc Compounds | 1 | 1991 | 10 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2011 | 93 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2011 | 118 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1991 | 122 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 157 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 1997 | 829 | 0.020 |
Why?
|
| Adult | 2 | 2013 | 77950 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1991 | 281 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 1989 | 103 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2005 | 1213 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1991 | 1618 | 0.020 |
Why?
|
| DNA | 4 | 2005 | 2693 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 1996 | 4143 | 0.020 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2007 | 15 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1987 | 99 | 0.020 |
Why?
|
| Glycosylation | 1 | 1987 | 213 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 997 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 1869 | 0.020 |
Why?
|
| Glucosides | 1 | 1987 | 64 | 0.020 |
Why?
|
| Phylogeny | 1 | 2009 | 826 | 0.020 |
Why?
|
| Retroviridae Proteins | 1 | 2006 | 20 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 289 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 2006 | 39 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1991 | 1234 | 0.020 |
Why?
|
| Hemagglutination | 1 | 1985 | 13 | 0.020 |
Why?
|
| Research | 1 | 2008 | 415 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 1985 | 70 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2005 | 80 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2005 | 264 | 0.020 |
Why?
|
| Colforsin | 1 | 2004 | 59 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1985 | 334 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1987 | 371 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2004 | 54 | 0.020 |
Why?
|
| Lac Operon | 1 | 2005 | 122 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2005 | 211 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2004 | 102 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2005 | 133 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2007 | 614 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 568 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 161 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 392 | 0.020 |
Why?
|
| Kinetics | 1 | 1987 | 2049 | 0.010 |
Why?
|
| Organometallic Compounds | 1 | 2004 | 191 | 0.010 |
Why?
|
| Muscles | 1 | 2005 | 416 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 445 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 1021 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1989 | 2283 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1987 | 850 | 0.010 |
Why?
|
| Epitopes | 1 | 1985 | 685 | 0.010 |
Why?
|
| Curriculum | 1 | 2008 | 860 | 0.010 |
Why?
|
| Mesoderm | 1 | 2005 | 404 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1037 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 3821 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 1020 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 1313 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 1029 | 0.010 |
Why?
|
| Genome | 1 | 2005 | 672 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 1013 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 2054 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 1694 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 2074 | 0.010 |
Why?
|
| Chromatin | 1 | 2005 | 942 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 1265 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1998 | 132 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2508 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 2450 | 0.010 |
Why?
|
| Myocardium | 1 | 2005 | 1313 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1998 | 221 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 2522 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1998 | 461 | 0.010 |
Why?
|
| Time Factors | 1 | 1991 | 12926 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1998 | 557 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 1879 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1998 | 408 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 1756 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1987 | 2819 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 4971 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 1996 | 22 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 5395 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 1996 | 86 | 0.010 |
Why?
|
| Somatostatin | 1 | 1996 | 114 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1998 | 1038 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1998 | 810 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 4078 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 1538 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1996 | 621 | 0.010 |
Why?
|
| Ammonium Sulfate | 1 | 1991 | 8 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 1991 | 23 | 0.010 |
Why?
|
| Chlorides | 1 | 1991 | 139 | 0.010 |
Why?
|
| Alkaloids | 1 | 1990 | 75 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1990 | 226 | 0.010 |
Why?
|
| Staurosporine | 1 | 1990 | 143 | 0.010 |
Why?
|
| Zinc | 1 | 1991 | 188 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1990 | 558 | 0.010 |
Why?
|
| Female | 1 | 1998 | 141928 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1990 | 2927 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1991 | 1203 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1990 | 1242 | 0.000 |
Why?
|